Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Doxorubicin-associated flare reactions.

C F Curran, J K Luce, J A Page

    Oncology Nursing Forum
    |May 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Doxorubicin administration can cause venous flare reactions, typically mild and resolving within 45 minutes for most patients. Understanding these flares is key to differentiating them from extravasation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aircraft Noise Generation and Assessment Section 5-Overall Vehicle System Noise, Part d-Sonic Boom.

    CEAS aeronautical journal·2021
    Same author

    Voltammetric reduction of nickel and cobalt dimethylglyoximate.

    Analytical chemistry·2011
    Same author

    Painful-feet syndrome among prisoners of war in the Far East.

    British medical journal·2010
    Same author

    Painful-feet Syndrome among Prisoners of War.

    British medical journal·2010
    Same author

    Federal regulation of tobacco products and products that treat tobacco dependence: are the playing fields level?

    Food and drug law journal·1999
    Same author

    Acute overdoses of tacrolimus.

    Transplantation·1996

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Doxorubicin is a widely used chemotherapy agent.
    • Venous flare reactions are a known, though not fully understood, side effect of doxorubicin infusion.

    Purpose of the Study:

    • To analyze the characteristics of venous flare reactions associated with doxorubicin administration.
    • To differentiate these flares from early doxorubicin extravasation.
    • To suggest methods for minimizing flare reactions.

    Main Methods:

    • Retrospective analysis of 539 cases of doxorubicin-associated venous flare reactions.
    • Clinical observation and documentation of reaction characteristics.
    • Comparison of flare reaction features with early extravasation signs.

    Main Results:

    Related Experiment Videos

    • 86% of patients experienced transient reactions resolving within 45 minutes.
    • Common symptoms included local urticaria (25%) and vein pain/stinging (6%).
    • Flare reactions showed seasonal incidence peaks and occurred in sporadic clusters.

    Conclusions:

    • Venous flare reactions to doxorubicin are generally benign and transient.
    • Distinct clinical features can differentiate flares from extravasation.
    • Preventive measures can be implemented to reduce flare occurrences.